Article Information
History
- September 11, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Abdelrahman Yousef1,
- Mahmoud Yousef1,
- Mohammad Zeineddine1,
- Aditya More1,
- Saikat Chowdhury1,
- Mark Knafl2,
- Paul Edelkamp3,
- Ichiaki Ito1,
- Yue Gu1,
- Vinay Pattalachinti1,
- Zahra Alavi Naini1,
- Fadl Zeineddine8,
- Jennifer Peterson1,
- Kristin Alfaro1,
- Wai Chin Foo4,
- Jeff Jin5,
- Neal Bhutiani6,
- Victoria Higbie1,
- Christopher Scally7,
- Bryan Kee1,
- Scott Kopetz1,
- Drew Goldstein9,
- Abhineet Uppal6,
- Michael G. White6,
- Beth Helmink7,
- Keith Fournier7,
- Kanwal Raghav1,
- Melissa Taggart4,
- Michael J. Overman1 and
- John Paul Shen1,*
- 1Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 2Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 3Department of Data Engineering & Analytics, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 4Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 5Department of Enterprise Dev & Integration, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 6Department of Colon and Rectal Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 7Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 8Department of Internal Medicine, Houston Methodist Hospital, Houston, TX, USA
- 9Palantir Technologies, Denver, CO, USA
- ↵*Corresponding Author:
John Paul Shen, MD Anderson Cancer Center, 1515 Holcombe BLVD., Houston, TX 77030, Phone; 832-728-8895 email: JShen8{at}mdanderson.org
Posted September 11, 2023.
The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma
